NEW YORK (MedscapeWire) Apr 19 — Donepezil ( Aricept) isn't just for Alzheimer's anymore. Results of a randomized, placebo-controlled trial presented April 17 at the American Academy of Neurology 54th ...

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study Adult female BCS exposed to ≥4 cycles of adjuvant ...

Postradiotherapy Neck Dissection for Lymph Node–Positive Head and Neck Cancer: The Use of Computed Tomography to Manage the Neck Thirty-four patients received donepezil 5 mg/d for 6 weeks, then 10 ...

Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...

When to raise the dose. Results of clinical trials demonstrate that higher doses are associated with better effects. The difference between donepezil 5 mg and 10 mg, galantamine 9 mg and 12 mg, and ...

All 32 patients completed the intervention. None of the patients exhibited acute diseases, such as pneumonia or fever that would warrant excluding the patients from the study protocol. Figure 1 ...